However, despite the arguments put forward by the applicant, the concerns regarding the active substance could not be eliminated.
Recital 11, Regulation (EU) 2019/344
In forcesince 28 Feb 2019cited 1×
Judgment of the General Court (Seventh Chamber) of 9 February 2022. AMVAC Netherlands BV v European Commission.Decision
Recitals 8 to 12 of the contested implementing regulation set out the reasons for the non-renewal as follows: ‘(8) On 18 May 2018 [EFSA] communicated to the Commission its conclusion on whether ethoprophos can be expected to meet the …
9 Feb 2022 · 62019TJ0317